Adult Clinical Oral Nutrition Market Size By Product Type (Milk Based Products, Fruit Drinks, Desserts, Savory Products), By Therapeutic Area (Malnutrition, Dysphagia, Glycemia, Cancer, Gastrointestinal Disorders), By Form (Powder, Liquid), By Sales Chann

Adult Clinical Oral Nutrition Market Size By Product Type (Milk Based Products, Fruit Drinks, Desserts, Savory Products), By Therapeutic Area (Malnutrition, Dysphagia, Glycemia, Cancer, Gastrointestinal Disorders), By Form (Powder, Liquid), By Sales Channel (Brick and Mortar, Hospital Pharmacies, E-commerce), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032

Global Adult Clinical Oral Nutrition Market is set to witness rapid growth between 2023 and 2032, primarily owing to the rising adoption of home healthcare systems, which require user-friendly and cost-effective oral nutritional supplements. Besides, the increasing geriatric population across the globe will also drive the market demand during the next decade. According to the Population Reference Bureau, the number of Americans aged 65 or older, is anticipated to reach 95 million by 2060.

In addition, the key providers in adult clinical oral nutrition market are also strengthening their position in the industry by entering valuable mergers and acquisitions and new product launches. To cite an instance, in June 2021, Vitaflo International announced the acquisition of Dr. Schär products and its production units. As per sources, this development will help Vitaflo rapidly expand its adult nutrition portfolio.

Overall, the adult clinical oral nutrition market has been segmented in terms of product, therapeutic area, form, sales channel, and region.

Based on the product, the savory products segment accounted for 10% revenue share in 2022 and is further set to witness noticeable gains through 2032. The segmental expansion can be credited to the increasing awareness and demand for flavored powders and ready-to-serve drinks, to balance the nutritional intake of a patient.

On the basis of the therapeutic area, the adult clinical oral nutrition market is likely to be characterized by the gastrointestinal disorders segment, which was valued at more than USD 581 million in 2022. The segment growth will be driven by the increasing cases of gastrointestinal diseases such as irritable bowel syndrome, gastroenteritis, and Crohn’s disease. According to a reliable study, more than 300 million people are affected by digestive diseases in the Mediterranean area and Europe every year.

In the context of sales channel, the hospital pharmacies segment will grow significantly by 2032. Since hospital pharmacies are economical, offer a range of products, are convenient, and have fewer risks, their demand will increase through 2032.

In the regional context, the North America adult clinical oral nutrition market is set to gain substantial traction over the next ten years. The regional market growth can be attributed to factors such as increasing cases of chronic ailments, increasing prevalence of malnutrition, and favorable government initiatives. For instance, according to the CDC, approximately 60% of the American population have at least one chronic disease, such as cancer, heart disease, or diabetes.